These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5867299)

  • 1. Dehydroxylation and deacetylation of N-hydroxy-N-2-fluorenylacetamide by rat liver and brain homogenates.
    Grantham PH; Weisburger EK; Weisburger JH
    Biochim Biophys Acta; 1965 Oct; 107(3):414-24. PubMed ID: 5867299
    [No Abstract]   [Full Text] [Related]  

  • 2. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
    Barry EJ; Gutmann HR
    Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid.
    King CM; Phillips B
    Science; 1968 Mar; 159(3821):1351-3. PubMed ID: 5644261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 5. On the significance and mechanism of the binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver ribonucleic acid in vivo.
    Irving CC; Veazey RA; Williard RF
    Cancer Res; 1967 Apr; 27(4):720-5. PubMed ID: 6025731
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 7. Transport of carcinogens: rat blood plasma and red cell binding of isotope after N-hydroxy-N-2-fluorenylacetamide.
    Weisburger JH; Grantham PH; Weisburger EK
    Life Sci; 1966 Jan; 5(1):41-5. PubMed ID: 5933654
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats.
    Weisburger JH; Grantham PH; Horton RE; Weisburger EK
    Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
    Barry EJ; Malejka-Giganti D; Gutmann HR
    Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
    [No Abstract]   [Full Text] [Related]  

  • 10. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
    Gutmann HR; Erickson RR
    J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic deacetylation of N-hydroxy-2-acetylaminofluorene by liver microsomes.
    Irving CC
    Cancer Res; 1966 Jul; 26(7):1390-6. PubMed ID: 5911580
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
    Blunck JM; Lees BJ
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding of N-hydroxy-2-acetylaminofluorene to replicating and non-replicating DNA in rat liver.
    Jackson CD; Irving CC
    Chem Biol Interact; 1970 Oct; 2(3):261-5. PubMed ID: 5524166
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of electrophilic N-acetoxyarylamines in cytosoles from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-4-acetylaminobiphenyl.
    Bartsch H; Dworkin C; Miller EC; Miller JA
    Biochim Biophys Acta; 1973 Mar; 304(1):42-55. PubMed ID: 4699998
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary hormones and the metabolism of N-hydroxy-N-2-fluorenylacetamide in female rats.
    Shirasu Y; Grantham PH; Weisburger JH
    Int J Cancer; 1967 Jan; 2(1):59-64. PubMed ID: 4292068
    [No Abstract]   [Full Text] [Related]  

  • 17. The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations.
    Lotlikar PD; Miller EC; Miller JA; Margreth A
    Cancer Res; 1965 Nov; 25(10):1743-52. PubMed ID: 5892967
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of the carcinogen N-2-fluorenylacetamide in germ-free and conventional rats.
    Grantham PH; Horton RE; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1970 Jan; 19(1):163-71. PubMed ID: 5507634
    [No Abstract]   [Full Text] [Related]  

  • 19. The deacetylation of N-arylacetamides in vitro.
    Gorrod JW
    Biochem J; 1971 Jun; 123(2):10P-11P. PubMed ID: 5127327
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of pituitary hormones and prefeeding N-hydroxy-N-2-fluorenylacetamide on the metabolism of this carcinogen and on physiologic parameters.
    Shirasu Y; Grantham PH; Yamamoto RS; Weisburger JH
    Cancer Res; 1966 Apr; 26(4):600-6. PubMed ID: 4287110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.